XGN · NASDAQ · Medical - Diagnostics & Research

Exagen (XGN)

Develops AVISE tests for diagnosis and monitoring of autoimmune disease.

$8.74
After hours−0.02 (−0.23%)
At close$8.76(+1.62%)